Mats Karlsson
Co-founded Pharmetheus in 2012, Board Chair and advising on drug development and pharmacometrics. Expertise includes methodological development and application of pharmacometrics to drug development and
Co-founded Pharmetheus in 2012, Board Chair and advising on drug development and pharmacometrics. Expertise includes methodological development and application of pharmacometrics to drug development and
Co-founded Pharmetheus in 2012, advising in client projects. Expertise includes pharmacometrics and model informed drug development with extensive experience in regulatory interactions in therapeutic areas
Co-founded Pharmetheus in 2012, advising in client projects and training Pharmetheus colleagues in pharmacometrics. Expertise includes development of pharmacokinetic-pharmacodynamic models of desired and adverse effects
Co-founded Pharmetheus in 2012, advising in client projects and training Pharmetheus colleagues in pharmacometrics. Expertise includes methodological development associated with building, evaluating and using pharmacometric
Pharmetheus offers consulting services focused on the application of quantitative approaches to support drug development decisions..